Search Results - "Price, Allan"

European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer by DE RUYSSCHER, Dirk, FAIVRE-FINN, Corinne, NESTLE, Ursula, HURKMANS, Coen W, LE PECHOUX, Cécile, PRICE, Allan, SENAN, Suresh

“…To derive recommendations for routine practice and clinical trials for techniques used in high-dose, high-precision thoracic radiotherapy for lung cancer. A…”
Get full text

Overcoming CYP1A1/1A2 Mediated Induction of Metabolism by Escalating Erlotinib Dose in Current Smokers by HUGHES, Andrew N, O'BRIEN, Mary E. R, PRICE, Allan, PETTY, W. Jeffrey, CHICK, Jonathan B, RANKIN, Elaine, WOLL, Penella J, DUNLOP, David, NICOLSON, Marianne, BOINPALLY, Ramesh, WOLF, Julie

“…Cigarette smoking induces CYP1A1/1A2 and is hypothesized to alter erlotinib pharmacokinetics. This study aimed to determine the maximum tolerated dose (MTD) of…”
Get full text

Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer by BUTTS, Charles, MURRAY, Nevin, DAVIS, Mary, MANSI, Janine, SMITH, Colum, VERGIDIS, Dimitrios, ELLIS, Paul, MACNEIL, Mary, PALMER, Martin, MAKSYMIUK, Andrew, GOSS, Glenwood, MARSHALL, Ernie, SOULIERES, Denis, CORMIER, Yvon, ELLIS, Peter, PRICE, Allan, SAWHNEY, Ravinder

“…To evaluate the effect of BLP25 liposome vaccine (L-BLP25) on survival and toxicity in patients with stage IIIB and IV non-small-cell lung cancer (NSCLC)…”
Get full text

Intensity-Modulated Radiotherapy, Not 3 Dimensional Conformal, Is the Preferred Technique for Treating Locally Advanced Disease With High-Dose Radiotherapy: The Argument Against by Price, Allan, PhD, MB BCh, FRCP(Ed), FRCR

“…Intensity-modulated radiotherapy (IMRT) allows the delivery of high-dose radiotherapy to target volumes, while sparing adjacent normal tissues. This has been…”
Get full text

Characterizing the phenomenon of radiation recall dermatitis by Camidge, R, Price, A

“…Radiation recall represents the 'recalling' of an effect similar in appearance to that of an acute radiation reaction in a previously irradiated field. The…”
Get full text

Variations in Target Volume Definition for Postoperative Radiotherapy in Stage III Non–Small-Cell Lung Cancer: Analysis of an International Contouring Study by Spoelstra, Femke O.B., M.D, Senan, Suresh, M.R.C.P., F.R.C.R., Ph.D, Le Péchoux, Cecile, M.D, Ishikura, Satoshi, M.D., Ph.D, Casas, Francesc, M.D, Ball, David, M.B., B.S., M.D., F.R.A.N.Z.C.R, Price, Allan, F.R.C.P., F.R.C.R., Ph.D, De Ruysscher, Dirk, M.D., Ph.D, van Sörnsen de Koste, John R., Ph.D

“…Purpose Postoperative radiotherapy (PORT) in patients with completely resected non–small-cell lung cancer with mediastinal involvement is controversial because…”
Get full text

Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer by MINGLEE, Siow, RUDD, Robin, WOLL, Penella J, OTTENSMEIER, Christian, GILLIGAN, David, PRICE, Allan, SPIRO, Stephen, GOWER, Nicole, JITLAL, Mark, HACKSHAW, Allan

“…Cancers rely on angiogenesis for their growth and dissemination. We hypothesized that thalidomide, an oral antiangiogenic agent, when combined with…”
Get full text

Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052) by O’Brien, Mary E.R, Gaafar, Rabab M, Popat, Sanjay, Grossi, Francesco, Price, Allan, Talbot, Denis C, Cufer, Tanja, Ottensmeier, Christian, Danson, Sarah, Pallis, Athanasios, Hasan, Baktiar, Van Meerbeeck, Jan P, Baas, Paul

“…Abstract Background This was a prospective phase II study of cisplatin and bortezomib (CB) in the first line treatment of malignant pleural mesothelioma (MPM)…”
Get full text

Phase III Study of Matrix Metalloproteinase Inhibitor Prinomastat in Non–Small-Cell Lung Cancer by BISSETT, Donald, O'BYRNE, Ken J, COLLIER, Mary A, SHEPHERD, Frances A, VON PAWEL, J, GATZEMEIER, Ulrich, PRICE, Allan, NICOLSON, Marianne, MERCIER, Richard, MAZABEL, Elva, PENNING, Carol, ZHANG, Min H

“…Matrix metalloproteinases (MMPs) degrade extracellular proteins and facilitate tumor growth, invasion, metastasis, and angiogenesis. This trial was undertaken…”
Get full text

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial by SCAGLIOTTI, Giorgio V, KORTSIK, Cornelius, NOVELLO, Silvia, BLATTER, Johannes, KAYITALIRE, Louis, CRINO, Lucio, PAZ-ARES, Luis, DARK, Graham G, PRICE, Allan, MANEGOLD, Christian, ROSELL, Rafael, O'BRIEN, Mary, PETERSON, Patrick M, CASTELLANO, Daniel, SELVAGGI, Giovanni

“…Purpose: To determine efficacy and toxicity of two pemetrexed-based regimens in chemonaive patients with locally advanced or metastatic non–small cell lung…”
Get full text

What Is the Role of Radiotherapy in Malignant Pleural Mesothelioma? by Price, Allan

“…Objective. A review of the evidence supporting the use of radiotherapy in patients with mesothelioma was performed. Methods. Relevant publications were…”
Get full text

Emerging developments of chemoradiotherapy in stage III NSCLC by Price, Allan

“…Many patients who present with stage III NSCLC are in their 70s with multiple comorbidities who are generally unfit to receive the standard chemoradiotherapy…”
Get full text

Increased But Error-Prone Nonhomologous End Joining in Immortalized Lymphoblastoid Cell Extracts From Adult Cancer Patients With Late Radionecrosis by Tan, Wu-Meng, M.B.B.Chir., Ph.D, Paterson, Malcolm C., Ph.D, Koo, Ghee Chong, Ph.D, Li, Hui Hua, Ph.D, Price, Allan, Ph.D., F.R.C.R., F.R.C.P, Loong, Susan L.E., M.D., F.R.C.R., F.R.C.P

“…Purpose To study nonhomologous end joining in extracts of two lymphoblastoid cell lines derived from patients with late radionecrosis after radiotherapy. Both…”
Get full text

Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial by Butts, Charles, Maksymiuk, Andrew, Goss, Glenwood, Soulières, Denis, Marshall, Ernie, Cormier, Yvon, Ellis, Peter M., Price, Allan, Sawhney, Ravinder, Beier, Frank, Falk, Martin, Murray, Nevin

“…Purpose To present an updated survival analysis of an open-label, parallel-group, phase IIB trial of BLP25 liposome vaccine (L-BLP25) in patients with stage…”
Get full text

The Thistle and the Rose : a Bacchian Analysis of the 'Problems' of Drug Use, Diversion and the Scottish Context by Price-Allan, Tracey

“…Background: Police diversion has emerged as a key strategy capable of reducing the harms associated with criminalisation by providing early interventions and…”
Get full text

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis by De Ruysscher, D., Lueza, B., Le Péchoux, C., Johnson, D.H., O'Brien, M., Murray, N., Spiro, S., Wang, X., Takada, M., Lebeau, B., Blackstock, W., Skarlos, D., Baas, P., Choy, H., Price, A., Seymour, L., Arriagada, R., Pignon, J.-P., De Ruysscher, D., Le Pechoux, C., Lueza, B., Paris, E., Pignon, J.P., Pijls-Johannesma, M., Veillard, A.S., Arriagada, Rodrigo, Baas, Paul, Blackstock, William, Chevret, Sylvie, Choy, Hak, Crawford, Jeffrey, Dafni, Urania, Dahlberg, Suzanne, De Ruysscher, Dirk, Hackshaw, Allan, Hasan, Baktiar, Johnson, David H., Le Pechoux, Cécile, Lebeau, Bernard, Lovato, James, Lueza, Béranger, Murray, Nevin, O’Brien, Mary, Paris, Emmanuelle, Pignon, Jean-Pierre, Pijls-Johannesma, Madelon, Price, Allan, Spiro, Stephen, Seymour, Lesley, Shibata, Taro, Skarlos, Dimosthenis, Takada, Minoru, Veillard, Anne-Sophie, Wang, Xiaofei

“…Chemotherapy (CT) combined with radiotherapy is the standard treatment of ‘limited-stage’ small-cell lung cancer. However, controversy persists over the…”
Get full text

Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) by Belderbos, José, Uitterhoeve, Lon, van Zandwijk, Nico, Belderbos, Huub, Rodrigus, Patrick, van de Vaart, Paul, Price, Allan, van Walree, Nico, Legrand, Catherine, Dussenne, Sonia, Bartelink, Harry, Giaccone, Giuseppe, Koning, Caro

“…Abstract A randomised phase III study was performed comparing sequential (S) and concurrent (C) chemo-radiotherapy (CRT) in non-small cell lung cancer (NSCLC)…”
Get full text

International comparisons of survival from lung cancer: pitfalls and warnings by Erridge, Sara C, Møller, Henrik, Price, Allan, Brewster, David

“…Population-based survival data can provide valuable comparative data on outcome but should be interpreted with caution. Differences in data collection and…”
Get full text

Patient perceptions of their decision to undergo palliative chemotherapy in the Edinburgh Cancer Centre by Bowden, Joanna, Gwyther, Beth, Price, Allan, Swan, Amanda, Nussey, Fiona, Hacking, Belinda, Shearer, Morven, Lloyd, Anna

“…The decision to undergo chemotherapy for incurable cancer demands informed discussions about the risks and benefits of proposed treatments. Research has shown…”
Get full text

Bioinformatics analysis of nanomaterials toxicity by Stelkic, Ana, Potkrajac, Dragana Mitic, Rakic, Branka, Price, Allan, Apic, Gordana

Get full text